RWD 2024
Real World Data Collecting real world data (RWD) from patients outside of the clinical trial setting can provide valuable insights for Sponsors, regulators, key industry stakeholders and end users of promising new drugsWhat is Real [...]
Careers 2024
Join Us. Be With Every Patient. See Open Positions Why Work at WEP Join WEP Clinical and unlock a world of limitless growth potential, extraordinary perks, and a resolute focus on advancing patient access.Uncover the [...]
Ana Conference Contacts
Fill out the short form so we can connect Facebook Linkedin
Prashant Conference Contacts
Fill out the short form so we can connect Facebook Linkedin
Heather Conference Contacts
Fill out the short form so we can connect Facebook Linkedin
Simon Conference Contacts
Fill out the short form so we can connect Facebook Linkedin
Building Stakeholder Engagement Through EAPs
BUILDING STAKEHOLDER ENGAGEMENT THROUGH EAPs Download our guide on leveraging Early Access Programs to engage healthcare professionals, payers, and empower eligible patients with early access to innovative therapies. Gain valuable insights, contribute to real-world [...]
International Recognition Procedure
International Recognition Procedure From January 2024, the MHRA is adopting the International Recognition Procedure, reflecting a strategic pivot towards an independent and collaborative regulatory framework for swift and secure drug authorizations in the UK. Our [...]
Voluntary Scheme for Branded Medicines, Pricing, Access and Growth (VPAG)
Voluntary Scheme for Branded Medicines, Pricing, Access and Growth (VPAG) The new VPAG scheme is due to come in effect in January 2024 lasting for 5 years. The scheme, which has been agreed between the [...]
News
WEP News All News20232021202220202019201820172016WEP CLINICAL HAS PARTNERED WITH PLUSULTRA PHARMA TO SUPPLY HYFTOR® TO PATIENTS IN EU/EEA COUNTRIES (WITH THE EXCEPTION OF GERMANY)1st December 2023/Read More2023WEP CLINICAL ANNOUNCES PARTNERSHIP WITH GERON CORPORATION FOR AN EXPANDED [...]